已收录 268921 条政策
 政策提纲
  • 暂无提纲
Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
[摘要] Lessons Learned.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 肿瘤学
[关键词]  [时效性] 
   浏览次数：2      统一登录查看全文      激活码登录查看全文